The FDA Wants To Hear Your Thoughts On Cannabis

A cannabis plant is seen under a red light, highlighting a leaf.

Would you like to share your thoughts with the Federal Gubbermint about cannabis? I hope so, because from now until October 31, they actually want to hear from you about your fondness for the devil’s lettuce.

Actually, they’re looking to hear from ALL people who have feelings about weed—including those who believe it’s a bad, scary, harmful drug that turns users into violent zombies—so it’s important that we make our voices heard.

While this isn’t as important as remembering to VOTE on November 6, consider it a dry run.

As Marijuana Moment reports, the World Health Organization (WHO)’s Expert Committee on Drug Dependence (ECDD) is meeting next month to consider the classification of cannabis and other substances such as fentanyl and several synthetic cannabinoids, and is now seeking to “gather information on the legitimate use, harmful use, status of national control and potential impact of international control.”

The FDA is gathering comments regarding “abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use”—the hope being that if enough people submit comments that are pro-cannabis, it may be removed from the Schedule I status it so erroneously holds right now.

Mind you, this is the FDA we’re talking about, so I’m not suggesting an investment into party hats just yet.

So, partake in whatever format you most enjoy, then do your part here (click on the “Comment Now!” box) by making the “type type” noises.

Josh Taylor is a well-known and successful entrepreneur in the legal cannabis space, producing B2B and B2C cannabis events, "Backstage Budtending" and upscale concierge services through his companies and His weekly syndicated newspaper column and features about cannabis ran for five years until March 2020.

Similar Articles